Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Non-Current Deferred Tax Liability (2016 - 2025)

Mesa Laboratories' Non-Current Deferred Tax Liability history spans 15 years, with the latest figure at $21.8 million for Q4 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 8.18% to $21.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.8 million, a 8.18% increase, with the full-year FY2025 number at $20.2 million, up 2.03% from a year prior.
  • Non-Current Deferred Tax Liability hit $21.8 million in Q4 2025 for Mesa Laboratories, up from $21.7 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for MLAB hit a ceiling of $44.3 million in Q4 2023 and a floor of $10.8 million in Q2 2021.
  • Historically, Non-Current Deferred Tax Liability has averaged $27.0 million across 5 years, with a median of $21.7 million in 2025.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: tumbled 65.37% in 2021 and later skyrocketed 245.14% in 2022.
  • Tracing MLAB's Non-Current Deferred Tax Liability over 5 years: stood at $41.1 million in 2021, then dropped by 10.18% to $36.9 million in 2022, then grew by 20.01% to $44.3 million in 2023, then tumbled by 54.49% to $20.2 million in 2024, then increased by 8.18% to $21.8 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for MLAB at $21.8 million in Q4 2025, $21.7 million in Q3 2025, and $21.6 million in Q2 2025.